Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents - Poll - MDSpire

Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents

  • By

  • Marwa Helal

  • Marwa Gamal

  • Ashraf A. Basuni

  • Walaa El Gendy

  • Ashraf Khalil

  • February 23, 2026

  • 0 min

Share

Original Source(s)

Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents

  • by Marwa Helal, Marwa Gamal, Ashraf A. Basuni, Walaa El Gendy, Ashraf Khalil

  • February 23, 2026

Related Content

Optimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts

Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages

Worldwide Rates and Determinants of Depression and Anxiety Among Individuals with Liver Cirrhosis: A Systematic Review and Meta-Analysis